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Cellular/Molecular
Expression of Nampt in Hippocampal and Cortical
Excitatory Neurons Is Critical for Cognitive Function
Liana Roberts Stein,1David F. Wozniak,2,3 Joshua T. Dearborn,2 Shunsuke Kubota,4 Rajendra S. Apte,1,4
Yukitoshi Izumi,2,3 Charles F. Zorumski,2,5 and Shin-ichiro Imai1
1Department of Developmental Biology, 2Department of Psychiatry, 3The Taylor Family Institute for Innovative Psychiatric Research, 4Department of
Ophthalmology, and 5Department of Anatomy and Neurobiology, Washington University School of Medicine, St. Louis, Missouri 63110
Nicotinamide adenine dinucleotide (NAD) is an enzyme cofactor or cosubstrate in many essential biological pathways. To date, the
primary source of neuronal NAD has been unclear. NAD can be synthesized from several different precursors, amongwhich nicotin-
amide is the substrate predominantly used inmammals. The rate-limiting step in the NAD biosynthetic pathway from nicotinamide is
performed by nicotinamide phosphoribosyltransferase (Nampt). Here, we tested the hypothesis that neurons use intracellular Nampt-
mediated NAD biosynthesis by generating and evaluating mice lacking Nampt in forebrain excitatory neurons (CaMKIINampt /
mice). CaMKIINampt / mice showed hippocampal and cortical atrophy, astrogliosis, microgliosis, and abnormal CA1 dendritic
morphology by 2–3 months of age. Importantly, these histological changes occurred with altered intrahippocampal connectivity and
abnormal behavior; including hyperactivity, some defects inmotor skills, memory impairment, and reduced anxiety, but in the absence
of impaired sensory processes or long-term potentiation of the Schaffer collateral pathway. These results clearly demonstrate that
forebrain excitatory neurons mainly use intracellular Nampt-mediated NAD biosynthesis to mediate their survival and function.
Studying this particular NAD biosynthetic pathway in these neurons provides critical insight into their vulnerability to pathophysio-
logical stimuli and the development of therapeutic and preventive interventions for their preservation.
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Introduction
Nicotinamide adenine dinucleotide (NAD) is a classic coen-
zyme used in many critical metabolic pathways such as glyco-
lysis, the tricarboxylic acid cycle, and mitochondrial oxidative
phosphorylation (Hirrlinger and Dringen, 2010). NAD is
also required for the synthesis of essential compounds, includ-
ing most nucleoside triphosphates and some amino acids
(Lunt and Vander Heiden, 2011), and for the enzymatic reac-
tions of poly-ADP-ribose polymerases (PARPs), CD38/
CD157 ectoenzymes, and sirtuins (Stein and Imai, 2012). In
mammals, NAD can be synthesized from four precursors:
nicotinamide, nicotinic acid, tryptophan, and nicotinamide
riboside (Houtkooper et al., 2010; Stein and Imai, 2012).
However, the predominantly used pathway is the conversion
of nicotinamide to NAD. The rate-limiting step of this path-
way is performed by nicotinamide phosphoribosyltransferase
(Nampt; Revollo et al., 2004; Revollo et al., 2007). In mice,
protein expression of Nampt is relatively high in brown adi-
pose tissue, liver, and kidney, but nearly undetectable in the
pancreas and brain (Kitani et al., 2003; Revollo et al., 2007;
Friebe et al., 2011).
Neurons must maintain high rates of oxygen consumption
and ATP synthesis for proper function (Barros and Deitmer,
2010).With such high neuronal metabolic activity, glia play an
important role in the generation and secretion of energy sub-
strates, such as glucose and monocarboxylic acids, to neurons
(Izumi et al., 1997; Pellerin et al., 2007; Barros and Deitmer,
2010; Hirrlinger and Dringen, 2010). However, it has been
poorly understood how neurons obtain sufficient NAD to
meet their energetic needs. Although Nampt-mediated NAD
biosynthesis maintains NAD levels in cultured neurons (Pit-
telli et al., 2010; Wang et al., 2011b), current work has implied
that glia may supply NAD to neurons because glia possess
efficient NAD biosynthesis machinery, whereas neurons
may not (Verderio et al., 2001; Sasaki et al., 2006). Therefore,
the fact that Nampt is selectively expressed in neurons of the
hippocampus and cortex (Zhang et al., 2010; Wang et al.,
2011b), key brain structures in cognition and emotion (Barkus
et al., 2010), raises an interesting question: is Nampt-mediated
Received Nov. 7, 2013; revised March 13, 2014; accepted March 19, 2014.
Author contributions: L.R.S., D.W., R.A., Y.I., C.Z., and S.I. designed research; L.R.S., J.D., S.K., and Y.I. performed
research; L.R.S., D.W., S.K., R.A., Y.I., C.Z., and S.I. analyzed data; L.R.S., D.W., Y.I., C.Z., and S.I. wrote the paper.
This work was supported by the National Institutes of Health (National Institute on Aging Grants AG024150 and
AG037457 to S.I.; National Institute of Child Health andHumanDevelopment P30 Center Grant HD062171 to D.F.W.;
National Institute of Mental Health Grant MH077791 to C.F.Z.; and Alafi Neuroimaging Laboratory, Hope Center for
Neurological Disorders, and NIH Neuroscience Blueprint Center supported by Core Grant P30 NS05105 to
Washington University) and the Ellison Medical Foundation (S.I.). We thank Kazuko A. O’Dell for help with the
electrophysiology.
S.I. served as a scientific advisory board member for Sirtris, a GSK company. S.I is also a cofounder of Metro
Midwest Biotech. C.F.Z. is affiliated with Sage Therapics. The remaining authors declare no competing financial
interests.
Correspondence should be addressed to Shin-ichiro Imai, MD, PhD, Professor, Department of Developmental
Biology, Department of Medicine (Joint), Washington University School of Medicine, Campus Box 8103, 660 South
Euclid Avenue, St. Louis, MO 63110. E-mail: imaishin@wustl.edu.
DOI:10.1523/JNEUROSCI.4730-13.2014
Copyright © 2014 the authors 0270-6474/14/345800-16$15.00/0
5800 • The Journal of Neuroscience, April 23, 2014 • 34(17):5800–5815
NAD biosynthesis the primary source of NAD for fore-
brain neurons?
We hypothesized that forebrain excitatory neurons depend
upon intracellular Nampt-mediated NAD biosynthesis. To test
this hypothesis, we generated CaMKIINampt / mice by
crossing Nampt flox/flox mice with CaMKIICre transgenic mice.
The CaMKIICre driver mediates recombination in forebrain
excitatory neurons, primarily in the hippocampal cornu ammo-
nis 1 (CA1) subregion and cortical layers II/III. Recombination
begins at postnatal day (P) 14 to P18, plateaus at P28, and spreads
progressively to the CA3 and dentate gyrus (DG) hippocampal
subregions (Tsien et al., 1996;Monteggia et al., 2007;Wang et al.,
2011a). We found that CaMKIINampt /mice exhibit hyper-
activity, impaired learning and memory, and reduced levels of
anxiety-like behaviors. In light of these remarkable phenotypes,
we conclude that forebrain excitatory neurons depend upon
intracellular Nampt-mediated NAD biosynthesis and can-
not obtain sufficient NAD metabolites from other sources
for successful cognitive function. Because CA1 sustains the
most damage in many prevalent diseases and conditions,
CaMKIINampt /mice provide critical insight into the im-
portance of Nampt-mediated NAD biosynthesis for thera-
peutic/preventive interventions against functional defects in
forebrain excitatory neurons.
Materials andMethods
Animals. Mice were maintained on a regular chow ad libitum diet (Pico-
Lab 5053 Rodent Diet 20; Lab Diets) on a 12 h light/dark cycle (lights
on from 6:00 A.M. to 6:00 P.M.). Parent lines were maintained as
homozygous colonies. Nampt flox/flox mice (Rongvaux et al., 2008)
were crossed to CaMKIICre mice (stock #005359, T29-1; The Jack-
son Laboratory; Tsien et al., 1996) to generate Namptf lox/;Cre dou-
ble heterozygous mice. Double heterozygous mice were bred to
Nampt flox/flox mice to obtain Nampt flox/flox;Cre (CaMKIINampt /)
mice. CaMKIINampt /mice were obtained in the expected Mende-
lian ratio. In all experiments, “control” mice were age-matched litter-
mates. The CaMKIICre driver mice were generated from 8.5 kb
genomic DNA fragment derived from the CaMKII gene (Tsien et al.,
1996). All animal procedures were approved by theWashington Univer-
sity Animal Studies Committee and were in accordance with National
Institutes of Health guidelines.
Immunohistochemistry. Mice were anesthetized by intraperitoneal in-
jection of ketamine and xylazine and perfused transcardially through the
left ventricle with cold 0.1 M phosphate buffer, pH 7.4, followed by a
phosphate-buffered solution of 4% paraformaldehyde (PFA). Brains
were postfixedwith 4%PFAovernight, equilibrated in 15% sucrose over-
night, equilibrated in 30% sucrose overnight, frozen, and stored at
80°C until sectioning. Then, 30 m coronal sections in a 1 in 8 series
were made by cryostat and stored at30°C in cryoprotectant until use.
Every eighth section was processed free floating. Tissue sections were
incubated in 50% formamide in 2 saline/sodium citrate at 65°C for 2 h
for Nampt immunostaining or 10mM citrate buffer at 65°C for 1 h for all
other antibodies before proceeding with the staining protocol. To re-
move endogenous peroxidase activity, all sections were incubated with
3% H2O2 for 10 min. Tissue sections were incubated in blocking/per-
meabilization solution containing 10%normal goat serum, 1%BSA, and
0.3% Triton-X in PBS for 45–60 min before 24 h of incubation with
primary antibodies in 5% normal goat serum and 0.1% Triton-X in PBS
at 4°C at the following dilutions: activated caspase 3 (1:500, #9661, rabbit;
Cell Signaling Technology), Iba1 (1:500, #019-19741, rabbit; Wako),
Gfap (1:1000,MAB360,mouse;Millipore),Map2 (1:500,M9942,mouse;
Sigma), Nampt (1:1000, ALX-804-717-C100, mouse; Alexis Biochemi-
cals), NeuN (1:500, MAB377, mouse; Millipore), PSD95 (1:500, #2507,
rabbit; Cell Signaling Technology), Synaptophysin (1:1000, S5768,
mouse; Sigma), VGlut1 (1:1000, 135 304, guinea pig; Synaptic Systems).
All antibody specificity was determined by lack of staining after omission
of primary or secondary antibodies. Alexa Fluor 627 (1:200), Alexa Fluor
488 (1:200), or Cy3 (1:400) conjugated-secondary antibodies (Jackson
ImmunoResearch) diluted in 2% normal goat serum, 1% BSA, and 0.1%
Triton-X in PBS were added for 2 h at room temperature. Detection of
Nampt, Synaptophysin, and Map2 was performed using the TSA-Plus
cyanine 5 kit (PerkinElmer). Nuclei were stained with 4,6-diamidino-2-
phenylindole (Sigma) for 10 min at room temperature. High-
magnification (20, 0.8 DIC II or 40 oil 1.3 DIC II) microscopic
imaging was performed using a Zeiss Axioimage.Z1 or an Olympus Na-
noZoomer 2.0-HT. Images were taken in z-stacks of 1 m steps through
the range of tissue section immunoreactivity. Quantification was per-
formed blinded to genotype on 2–3 tissue sections per animal. Verifica-
tion of colocalizationwas achieved by performing 3D rendering on stacks
of Z-images with ImageJ.
Golgi-Cox staining and analysis. Mice were decapitated and the brains
were quickly removed from the skull, washed in MilliQ water, and pro-
cessed immediately for impregnation using the Rapid GolgiStain kit ac-
cording tomanufacturer’s instructions (FDNeuroTechnologies). Brains
were sectioned using a cryostat at 22°C at a thickness of 100 m.
Golgi-impregnated neurons were filled completely such that their soma
and dendrites were clearly visible. Neurons located in CA1’s stratum
pyramidale were traced with ImageJ’s NeuronJ plugin and Sholl analysis
was performedwith ImageJ’s Sholl analysis plugin, with spheres centered
on the soma, beginning at a radius of 20 m and increasing in size by 10
m increments.
Western blotting. Protein extracts (15–50 g) were prepared from
acutely isolated mouse hippocampi flash frozen in liquid nitrogen and
stored at80°C until use, as described previously (Yoshino et al., 2011).
Membranes were incubated with primary antibodies in TBST overnight
at 4°C. Primary antibodies used: activated caspase 3 (1:1000, #9661, rab-
bit; Cell Signaling Technology), Gfap (1:3000, MAB360, mouse; Milli-
pore), LC3 (1:2000; NB600-1384, rabbit; Novus),Map2 (1:1000,M9942,
mouse; Sigma), Nampt (1:3000; ALX-804-717-C100, mouse; Alexis Bio-
chemicals), Spectrin (1:1000, MAB1622, mouse; Millipore), Synapto-
physin (1:1000, S5768, mouse; Sigma), and -tubulin (1:500, sc-9104,
rabbit; Santa Cruz Biotechnology).
Quantitative real-time RT-PCR. Total RNA was isolated from mouse
hippocampi flash frozen in liquid nitrogen and stored at 80°C before
extraction using the RNeasy kit (QIAGEN). RNAwas reverse transcribed
into cDNAwith theHigh Capacity cDNAReverse Transcription kit (Ap-
plied Biosystems). Quantitative real-time RT-PCR was conducted with
the TaqMan Fast Universal PCR Master mix and appropriate TaqMan
primers for each gene in the GeneAmp 7500 fast sequence detection
system (Applied Biosystems). Relative expression levels were calculated
for each gene by normalizing to GAPDH levels and then to a control.
Experimental design of behavioral studies. Behavioral tests were con-
ducted on two separate cohorts of CaMKIINampt / and littermate
control mice. The first cohort of CaMKIINampt / mice (n  16; 7
male, 8 female) and littermate control mice (n  15; 7 male, 8 female)
was evaluated on the 1 h locomotor activity test, battery of sensorimotor
measures, Morris water maze (MWM) navigation task, and conditioned
fear, in that order. The second, naive cohort of CaMKIINampt /
mice (n  16; 7 male, 9 female) and littermate control mice (n  15; 7
male, 8 female) was tested on the elevated plus maze (EPM). Behavioral
tests were conducted by observers unaware of the genotypes of individual
mice.
One hour locomotor activity and sensorimotor battery. Locomotor ac-
tivity was evaluated using transparent (47.6  25.4  20.6 cm high)
polystyrene enclosures and computerized photobeam instrumentation
as described previously (Wozniak et al., 2004; Dougherty et al., 2013).
General activity variables (total ambulations, vertical rearings, alongwith
indices of emotionality including time spent, distance traveled and en-
tries made in a 33 11 cm central zone, and distance traveled in a 5.5 cm
contiguous peripheral zone were analyzed. The following day, mice were
evaluated on a battery of sensorimotor tests designed to assess balance
(ledge and platform), strength (inverted screen), coordination (pole and
inclined screens), and initiation of movement (walking initiation), as
described previously (Wozniak et al., 2004; Grady et al., 2006). For the
walking initiation test, a mouse was placed on a surface in the center of a
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21  21 cm square marked with tape and the time the mouse took to
leave the square was recorded. During the balance tests, the time that a
mouse remained on a Plexiglas ledge (0.75 cm wide) or a small circular
wooden platform (3.0 cm in diameter) elevated 30 or 47 cm, respectively,
was recorded. The pole test involved placing a mouse “head up” with its
forepaws on top of a finely textured rod (diameter 8 mm; height 55 cm)
and timing how long it took the mouse to turn and climb down the pole.
If the mouse fell off the pole during a trial, it received a maximum score
of 120 s. The screen tests were conducted by placing a mouse head-
oriented down in the middle a wire mesh grid measuring 16 squares per
10 cm, elevated 47 cm and angled at 60° or 90°. The time the mouse
required to turn 180° and climb to the top of the apparatus was recorded.
For the inverted screen, a mouse was placed on the screen as described
previously in this section.Once themouse appeared to have a secure grip,
the screen was inverted 180° and the time the mouse remained on the
screenwas recorded. Each test had amaximum timeof 60 s, except for the
pole test, which had a maximum time of 120 s. The averaged time of two
trials for each test was used for the analyses.
MWMnavigation. Spatial learning andmemory were evaluated by the
MWM using a computerized tracking system (ANY-maze; Stoelting) as
described previously (Wozniak et al., 2004; Dougherty et al., 2013) the
day after the completion of the sensorimotor battery. Cued (visible plat-
form, variable location) and place (submerged, hidden platform, con-
stant location) trials were conducted and escape path length, latency, and
swimming speeds were computed. The cued condition involved con-
ducting four trials per day (60 s maximum per trial) for two consecutive
days with the platform being moved to a different location for each trial
using a 30 min intertrial interval (ITI) and with very few distal spatial
cues being present to limit spatial learning. Performance was analyzed
across four blocks of trials (two trials/block). Three days later, place trials
were initiated to assess spatial learning, in which mice were required to
learn the single location of a submerged platform in the presence of
several salient distal spatial cues. During place trials, the mice received 2
blocks of 2 consecutive trials (60 s maximum for a trial; 30 s ITI spent on
platform)with each block being separated by2 h and eachmouse being
released from a different quadrant for each trial. The place trials data
were analyzed over five blocks of trials (four trials/block), in which each
block represented the performance level for each of five consecutive days.
A probe trial (60 s maximum) was administered1 h after the last place
trial on the fifth day of training with the platform being removed and the
mouse being released from the quadrant opposite to where the platform
had been located. Time spent in the various pool quadrants, including
the target quadrant where the platform had been placed, and crossings
over the exact platform location served as the dependent variables.
Conditioned fear. Conditioned fear was evaluated as described previ-
ously (Wozniak et al., 2007; Sato et al., 2012) 54 d after examining spatial
learning andmemory in theMWM. Briefly, mice were trained and tested
in two Plexiglas conditioning chambers (26 cm 18 cm, and 18 cmhigh;
Med-Associates), with each chamber containing distinct and different
visual, odor, and tactile cues. Each mouse was placed into the condition-
ing chamber for a 5min trial and freezing behavior was quantified during
a 2 min baseline period. Beginning at 3 min and at 60 s intervals thereaf-
ter, the mice were exposed to 3 T/S pairings, with each pairing including
a 20 s presentation of an 80 dB tone (conditioned stimulus; CS) consist-
ing of broadband white noise followed by a 1.0 mA continuous foot
shock (unconditioned stimulus; US) presented during the last second of
the tone. Broadband white noise was used instead of a frequency-specific
tone in an effort to avoid possible auditory deficits that might occur with
age. The mice were placed back into the conditioning chamber the fol-
lowing day and freezing behavior was quantified over an 8 min period to
evaluate contextual fear conditioning. Twenty-four hours later, the mice
were placed into a different chamber containing different cues. Freezing
behavior was quantified during a 2 min “altered context” baseline and
over the subsequent 8 min, during which time the auditory cue (tone;
CS) was presented. Freezing was quantified using FreezeFrame image
analysis software (Actimetrics), which allowed for simultaneous visual-
ization of behavior while adjusting a “freezing threshold,” which catego-
rized behavior as freezing or not freezing during 0.75 s intervals. Freezing
was defined as no movement except for that associated with normal
respiration and the data are presented as percentage of time spent freez-
ing. Shock sensitivity was evaluated after completion of the conditioned
fear testing according to our previously described procedures (Khuchua
et al., 2003).
EPM. Anxiety-like behaviors were assessed using the EPM according
to our previously described procedures (Schaefer et al., 2000; Dougherty
et al., 2013).Our apparatus consisted of twoopposing open arms and two
opposing enclosed arms (36 6.1 15 cm) that extended from a central
platform (5.5  5.5 cm) constructed of black Plexiglas. The maze was
equipped with pairs of photocells configured in a 16 (x-axis)  16 ( y-
axis) matrix, the output of which was recorded by a computer and inter-
face assembly (Kinder Scientific). A system software program
(MotorMonitor; Kinder Scientific) enabled the beam-break data to be
recorded and analyzed to quantify time spent, distance traveled, and
entriesmade into the open and closed arms and center area. To adjust for
differences in general activity, the percentage of distance traveled, time
spent, and entries made into the open arms out of the totals (open arms
 closed arms) for each variable were also computed. Test sessions were
conducted in a dimly lit room where light was provided by two 13-watt
blacklight bulbs (EcoBulbs; Feit) and each session began by placing a
mouse in the center of the maze and allowing it to freely explore the
apparatus. Each test session lasted 5 min and the mice were tested over 3
consecutive days.
LTP. LTP was evaluated using previously described methods (Bukalo
andDityatev, 2006; Tokuda et al., 2010). Briefly, hippocampal slices were
prepared from 60-d-old mice. Mice were anesthetized with isoflurane
and decapitated. Hippocampi were rapidly dissected and placed in arti-
ficial CSF (ACSF) containing the following (in mM): 124 NaCl, 5 KCl, 2
MgSO4, 2 CaCl2, 1.25 NaH2PO4, 22 NaHCO3, 10 glucose, gassed with
95%O2–5%CO2 at 4–6°C, and sectioned transversely into 400–450m
slices using a rotary slicer. Acutely prepared slices were placed in an
incubation chamber containing gassed ACSF for at least 1 h at 30°C.
Slices were then transferred individually to a submersion-recording
chamber. Experiments were performed at 30°C with continuous perfu-
sion of ACSF at 2 ml/min. Extracellular recordings were obtained from
the CA1 apical dendritic region (stratum radiatum) for analysis of field
EPSPs (fEPSPs) and from the pyramidal cell layer (stratum pyramidale)
for analysis of fiber volleys and population spikes using 2 M NaCl glass
electrodes (5–10 M). Responses were elicited with 0.1 ms constant
current pulses through a bipolar electrode in the Schaffer collateral path-
way. fEPSPs were measured by the maximal slope of their rising phase
and fiber volleys and population spikes weremeasured as maximal peak-
to-trough amplitudes. A baseline (control) input-output (IO) curve was
obtained to determine stimulus intensities for subsequent analyses. IO
curves were generated using stimuli of six different intensities to allow
determination of half-maximal responses. The smallest stimulus was set
to evoke a response less than half maximal and the largest stimulus was
designed to evoke a fully saturated response. During an experiment,
evoked fEPSPs were monitored by applying single stimuli to the Schaffer
collateral pathway every 60 s at an intensity sufficient to elicit half max-
imal responses. After establishing a stable baseline, LTP was induced by
applying a single 100 Hz  1 s high-frequency stimulus (HFS) using a
stimulus of the same intensity. IO curves were repeated 60 min after
delivery of low-frequency stimulation (LFS; 1 Hz 900 pulses) and then
60min after delivery ofHFS (100Hz 100 pulses 1 s) to determine the
magnitude of LTP based on changes in half maximal responses.
For investigation of paired-pulse plasticity, dual stimuli of identical
intensity were delivered at an interval of 21 ms. The stimulus intensity
was initially set below threshold for evoking responses and increased in a
stepwise fashion every 10 s until six pairs of stimuli were administered.
Methods for analyzing paired-pulse changes in somatic excitability based
on IO curves are detailed in the Figure 5C legend.
Statistical analyses. All numerical data are presented as mean SEM.
Statistical significance between control and experimental samples was
determined by unpaired Student’s t tests with p 	 0.05 representing a
statistically significant difference. For the behavioral data, ANOVAmod-
els were used. Repeated-measures ANOVA (rmANOVA) models con-
taining two between-subjects variables (genotype and sex) and one
within-subject (repeated-measures) variable (e.g., blocks of trials) were
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typically used to analyze theMWM, conditioned fear, and EPMdata. The
Huynh-Feldt adjustment of  levels was used for all within-subject
effects containingmore than two levels to protect against violations of
sphericity/compound symmetry assumptions underlying rmANOVA
models. Typically, one-way ANOVA models were used to analyze dif-
ferences between groups for measures in the 1 h locomotor activity and
the sensorimotor battery tests. Pairwise comparisons were conducted
after relevant, significant overall ANOVA effects and were subjected to
Bonferroni correction when appropriate, al-
though planned comparisons were also
conducted.
Results
CaMKIINampt /mice are overtly
normal but show altered CA1
morphology at 2–3 months of age
At2–3months of age,CaMKIINampt /
mice lookedovertlynormal relative to litter-
mate control mice (Fig. 1A). The body
weights of female CaMKIINampt /
mice were indistinguishable from control
mice (Student’s t test, p 0.38, n 22–26),
whereas the body weights of male
CaMKIINampt / mice were slightly,
but significantly, lower than control mice
(Fig. 1B; Student’s t test, p  0.0001, n 
20–26). Because the CaMKIICre driver
mediates recombination in excitatory neu-
rons of the forebrain, we examined the
morphology of CaMKIINampt / and
control brains by gross inspection andH&E
staining (Fig. 1C–E). CaMKIINampt /
brains looked slightly smaller than control
brains at 2–3months of age (Fig. 1C). Con-
sistent with this observation, we noticed a
visible decrease in the thickness of the CA1
stratum pyramidale and an increase in total
cells present in the stratum radiatum and
stratum oriens. Quantitatively, the total
brain weight of CaMKIINampt / mice
was 9% smaller than that of control mice
(Fig. 1F; Student’s t test, p  0.03, n  5).
Similarly, the total weight of each hip-
pocampi in CaMKIINampt /mice was
16% smaller than that of control mice (Fig.
1G; Student’s t test, p 0.01, n 5). Using
DAPI staining to quantify the cell loss, we
found that CaMKIINampt / mice had
44% fewer DAPI cells in (Student’s t test,
p 0.00001, n 5) and a 54% decrease in
thewidthofCA1’s stratumpyramidale (Fig.
1H,I; Student’s t test, p 0.00001, n 5).
To validate the recombination pattern
produced by the CaMKIICre driver, we
examined Nampt protein expression by
immunohistochemistry in 2- to 3-month-
old CaMKIINampt / and control
mice. In both genotypes, Nampt was ex-
pressed in neurons, but not astrocytes, of
the hippocampus, as shown previously
(Zhang et al., 2010;Wang et al., 2011b; Fig.
2A–C). However, CaMKIINampt /
mice exhibited a striking loss of Nampt im-
munoreactivity in neurons of the CA1 sub-
regionof the hippocampus (Fig. 2A) and, to
a lesser extent, in neurons of the DG and CA3 subregions (Fig.
2B,C). Quantification of these differences in CA1 revealed that
CaMKIINampt / mice had 38% fewer cells expressing
Nampt (Fig. 2D; Student’s t test, p  0.0007, n  5). Immuno-
blotting whole hippocampal extracts showed a significant 30%
decrease in Nampt protein levels inCaMKIINampt / relative
Figure 1. CaMKIINampt / mice are overtly normal but show altered CA1 morphology at 2–3 months of age. A, Repre-
sentative images of CaMKIINampt / and control mice. B, Body weights of CaMKIINampt / mice (n 22–26) and
control mice (n 20–26). C, Representative images of the brains of CaMKIINampt / and control mice. D, H&E staining of
coronal brain sections. Scale bars, 500m. E,Magnification of the CA1hippocampal subregion fromD. Scale bars, 50m. F, Brain
weights of CaMKIINampt / and control mice (n 5). G, Hippocampal weights of CaMKIINampt / and control mice
(n 5). H, I, Quantification of immunohistochemistry in the CA1 stratum pyramidale (n 5). H, The number of DAPI cells
present per length of the CA1 stratum pyramidale. I, Width of the CA1 stratum pyramidale, calculated as CA1 area per CA1 length.
Data are presented as mean SEM. *p	 0.05; **p	 0.01; ***p	 0.001.
Stein et al. • Forebrain Nampt Is Required for Cognitive Function J. Neurosci., April 23, 2014 • 34(17):5800–5815 • 5803
to control mice (Fig. 2E; 0.54  0.04 in
CaMKIINampt /mice vs 0.77 0.04
in controlmice at 6–7months of age; Stu-
dent’s t test, p  0.006, Nampt intensity
normalized by -tubulin, n  9). This
30% reduction in Nampt protein expres-
sion is consistent with the CA1-specific
nature of the deletion. To further confirm
the reduction in Nampt, we measured
NAD levels in hippocampal extracts of
2- to 3-month-old CaMKIINampt /
and control mice (Fig. 2F). Hippocampal
NAD levels in CaMKIINampt /
mice were reduced 26% relative to control
mice (Student’s t test, p 0.007, n 12–
14), whereas ATP levels between the two
genotypes were indistinguishable (Fig.
2G; Student’s t test, p  0.34, n  12).
CaMKIINampt / mice also exhibited
identicalmortality rates relative to control
mice through 14 months of age (the latest
age checked, data not shown).
CaMKIINampt /mice exhibit
astrogliosis andmicrogliosis in the
forebrain
As in the hippocampus, Nampt immu-
noreactivity appeared to be reduced in
the cortex of CaMKIINampt / mice
relative to control mice (Fig. 3A). In
control mice, cortical layer I was easily
distinguishable by its low cell density
(Fig. 3A,B). In contrast, the cortical lay-
ers of CaMKIINampt / mice were
indistinguishable by cell density. Al-
though loss of NeuN neurons was
mainly prevalent in CA1, all three hip-
pocampal subregions and the cortex
also demonstrated a dramatic increase
in Gfap immunoreactivity (Fig. 3A),
suggesting astrogliosis. Because of this
massive astrogliosis, we investigated
whether the populations of other cell
types were affected. Immunohisto-
chemistry for Iba1 also revealed exten-
sive microglial activation in all
hippocampal subregions and the cortex,
indicative of an inflammatory response
(Fig. 3B). Quantitative PCR analysis re-
vealed a 6-fold increase in Gfap (Student’s t test, p 
0.0000004, n  11–14) and a 2.3-fold increase in Iba1 (Stu-
dent’s t test, p  0.002, n  11–14) mRNA expression in the
hippocampi of CaMKIINampt / mice relative to control
mice (Fig. 3C).
Due to the substantial neuronal loss in the CA1 subregion of
2- to 3-month-old CaMKIINampt / mice (Figs. 1E, 2A), we
investigated whether the Nampt-deficient neurons were dying.
Immunohistochemistry for TUNEL (Fig. 3B) or activated
caspase 3 (Fig. 3D), markers of cell death, revealed very few
positive cells in either genotype, indicating that neither apo-
ptosis nor necrosis was occurring at substantial levels at this
age. Consistent with this notion, immunoblotting for acti-
vated caspase 3 failed to detect any differences between 2- and
3-month-old CaMKIINampt / and control mice (Fig. 3E).
To assess autophagy, we determined the formation of LC3B-II,
an autophagosome-membrane-associated form of LC3B that
correlates with the induction of autophagy. However, immuno-
blotting for LC3B failed to detect any differences between
CaMKIINampt / mice and control mice in the levels of the
LC3B-I and LC3B-II species (Fig. 3E). To assess excitotoxicity, we
checked spectrin breakdown products: the 280 kDa spectrin pro-
tein can be cleaved to unique 150 and 145 kDa fragments by
calpain (Bevers and Neumar, 2008). The 145 kDa product of
Figure 2. CaMKIINampt /mice show prominent deletion of Nampt and cell loss in CA1 at 2–3 months of age. A–C,
Representative images of Immunofluorescence for DAPI (blue), Nampt (red), and NeuN (green) in coronal sections (n 5).
Scale bars, 20M. In control mice, NeuN neurons express Nampt. This expression is greatly reduced in the DG, CA3, and
CA1 of CaMKIINampt /mice. D, Quantification of immunohistochemistry in the CA1 stratum pyramidale (n 5). The
percentage of DAPI cells that express Nampt. E, Representative immunoblots of hippocampal extracts of
CaMKIINampt / and control mice at 6 –7 months of age. F, HPLC analysis in hippocampal extracts of
CaMKIINampt /mice (n 14) and control mice (n 12) shows significantly reduced NAD levels. G, HPLC analysis
in hippocampal extracts of CaMKIINampt / and control mice shows similar ATP levels (n 12). Data are presented as
mean SEM. *p	 0.05; **p	 0.01; ***p	 0.001.
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spectrin appeared to increase in CaMKIINampt /mice rela-
tive to control mice, implying some calpain activation due to
excitotoxicity (Fig. 3E; control mice: 0.73  0.04;
CaMKIINampt / mice: 0.93  0.06; Student’s t test, p 
0.012, n 9). The increase in Gfap gene expression was also seen
at the protein level (Fig. 3E).
CaMKIINampt /mice show
specific CA1 and cortical dendritic loss
and swelling but intact expression of
synaptic markers at 2–3 months of age
Calpain activation is known to result in loss
of Map2 immunoreactivity upon injury
(Matesic and Lin, 1994; Pettigrew et al.,
1996; Minger et al., 1998). Intriguingly, we
found that, in CaMKIINampt / mice,
CA1 stratum oriens exhibited a complete
loss ofMap2 staining and the stratumradia-
tum highlighted a sparse layer of swollen
dendrites (Fig. 4A). In contrast, control
mice exhibited long, string-like apical and
basalMap2dendrites in the stratumradia-
tum and stratum oriens, respectively (Fig.
4A), as reported previously (Kitagawa et
al., 1989; Kwei et al., 1993; Matesic and
Lin, 1994; Folkerts et al., 1998; Jalava et al.,
2007). No Map2 immunostaining was
found in DAPI nuclei or in the myelin
tracts. Loss of Map2 dendrites upon in-
jury is thought to occur both before and
during spectrin degradation by calpain
(Matesic and Lin, 1994; Pettigrew et al.,
1996; Minger et al., 1998). Therefore, to
determine whether the observed changes
were specific to Map2, we assessed the lo-
calization of this cytoskeletal protein.
Spectrin immunoreactivity was indistin-
guishable between CaMKIINampt /
and controlmice, indicating that, whereas
calpain-mediated cleavage of spectrin had
increased, its degradation had not (data
not shown).
To quantify these changes in dendritic
arborization, we performed Golgi-Cox
impregnation and Sholl analysis on im-
pregnated cells in CA1’s stratum pyrami-
dale. CaMKIINampt /mice showed a
reduction in dendritic arborization, with
a significant decrease in intersections at
multiple distances from the soma (Fig.
4B,C; Student’s t tests, p 0.01–0.002, n
4–5 mice, 10 neurons per mouse). This
analysis also revealed a drastic reduction in
the number of impregnated neurons, sug-
gesting a reduced neuronal population
(control mice: 189  8 cells/mm2;
CaMKIINampt / mice: 83  17 cells/
mm2; Student’s t test,p0.0008,n4–5).
Despite these remarkable histological
changes, mRNA expression of markers of
excitatory neurons (NR1, NR2A, NR2B),
synapses (Dlg4), GABAergic signaling
(GabaR1,GabaR2), or synaptic plasticity
(Bdnf) were all similar between 2- and
3-month-old CaMKIINampt / and control mice (Fig. 4D).
Only two immediate early genes (Arc, Egr1) showed significant re-
duction in their mRNA expression in CaMKIINampt / mice
relative to controlmice (Fig. 4D; Student’s t tests,Arc:p0.001,n
11–14; Egr1: p 0.002, n 11–14).
Figure 3. CaMKIINampt /mice show extensive CA1 and cortical astrogliosis and microgliosis without obvious cell death
at 2–3months of age. A, B,D, Representative images of Immunofluorescence (n 5–9) taken in coronal sections. Scale bars, 50
M. A, Immunofluorescence for DAPI (blue), Nampt (red), and Gfap (green). B, Immunofluorescence for DAPI (blue), Iba1 (red),
and TUNEL (green). C, Quantitative PCR analysis with hippocampal RNA samples of CaMKIINampt / mice (n 11) and
controlmice (n 14) shows a 6-fold increase inGfap and a 2.3-fold increase in Iba1mRNAexpression.D, Immunofluorescence for
DAPI (blue) and activated caspase 3 (red) shows no obvious difference in cell death between CaMKIINampt / mice and
controls. Arrow highlights a rare activated caspase 3 cell. E, Representative images of immunoblots in CaMKIINampt /
mice (n4) and controlmice (n5) shows a lack of overt cell death (activated caspase 3: 17, 19 kDa; LC3: 17, 19 kDa) and a slight
increase in the 145/150 kDa spectrin (280, 145, 150, 100 kDa) breakdown product and the presence of astrogliosis (Gfap: 55 kDa).
Immunoblots were normalized by Gapdh (36 kDa). Data are presented as mean SEM. *p	 0.05; **p	 0.01; ***p	 0.001.
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To determine whether this dendritic
abnormality extended to the synapses, we
performed immunohistochemistry for
synaptophysin, a marker for presynaptic
terminals; vesicular glutamate transporter
1 (VGlut1), a marker of glutamatergic
synaptic vesicles (Santos et al., 2009); and
postsynaptic density protein 95 (PSD95),
a marker of excitatory postsynaptic densi-
ties (Aarts and Tymianski, 2004) in the
stratum radiatum. Surprisingly, the inten-
sity of synaptophysin was overtly normal
in CaMKIINampt / mice (Fig. 4E),
confirming no major defects in synaptic
protein expression. Consistent with this,
and supporting the notion of a CA1-
specific effect, immunoblotting for Map2
and synaptophysin in hippocampal ex-
tracts failed to detect any differences be-
tween CaMKIINampt / and control
mice (Fig. 4F). VGlut1 expression in the
hippocampus was significantly higher in
CaMKIINampt /mice both when as-
sessed by mean intensity (Fig. 4G, control
mice: mean intentisy 111  7 arbitrary
units [AU], n 6; CaMKIINampt /
mice: mean intensity 136 6 AU, n 7;
Student’s t test, p  0.02) and by the
percentage of CA1 area covered by the
thresholded VGlut1 immunoreactive
signal (control mice: 16  9% of CA1
area, n  6; CaMKIINampt / mice:
49 9% of CA1 area, n 7; Student’s t
test, p  0.02). In contrast, PSD95 ex-
pression in the hippocampus trended to
decrease in CaMKIINampt / mice
(mean intensity 85 4 AU, n 7) relative
to controlmice (mean intensity 95 4 AU,
Student’s t test, p 0.12, n 6).
Although these normal expression pat-
terns do not confirm correct localization
of these proteins, they suggest that
CaMKIINampt / mice have intact
synaptic components. In addition, be-
cause VGlut1 expression levels determine
the amount of glutamate stored and re-
leased per vesicle (Wojcik et al., 2004;Wil-
son et al., 2005), the increase in VGlut1
expression and decrease in PSD95 expres-
sion could indicate an imbalance between
presynaptic glutamate release and post-
synaptic densities.
CaMKIINampt /mice exhibit
altered hippocampal physiology at 2–3
months of age
With such overt effects on dendritic mor-
phology, we suspected that CA1 synaptic
functionmight be altered. To test this pos-
sibility,we stimulated the Schaffer collat-
eral inputs in the CA1 region of
hippocampal slices from P60 mice.
Stimulation of the Schaffer collateral in-
Figure4. CaMKIINampt /mice showaltereddendritic integrity in the absence of overt synapse loss in CA1 at 2–3months
of age. A, Representative images of Immunofluorescence for DAPI (blue) and Map2 (green) in control and CaMKIINampt /
coronal sections (n 5–9). Scale bars, 50m. There is a reduction of the number and change in the orientation of CA1 dendrites
of CaMKIINampt /mice relative to control mice.B, C, Golgi-Cox impregnation of CA1 pyramidal neurons.B, Sholl analysis of
impregnated CaMKIINampt / showed a reduction in dendritic arborization. C, Representative traces of Golgi-Cox impregna-
tion in control andCaMKIINampt / coronal sections (n4–5). Scalebars, 50m.D, QuantitativePCRanalysis inhippocam-
pal RNA samples of CaMKIINampt /mice (n5–11) and control (n5–14)mice showsno change inmarkers of excitatory
neurons (NR1, NR2A, NR2B), synapses (Dlg4 ), interneurons (GabaR1, GabaR2), or synaptic plasticity (Bdnf ), but a reduction in
immediate early genes (Arc, Egr1).E, Immunofluorescence for DAPI (blue) and Synaptophysin (green) showsnoobvious difference
in Synaptophysin intensity between CaMKIINampt / and control mice. Scale bars, 50 m. F, Representative images of
immunoblots in CaMKIINampt /mice (n 4) and control mice (n 5) show similar levels of Map2 and Synaptophysin. C,
Control; N, CaMKIINampt /.G, Immunofluorescence for DAPI (blue) andVGlut1 (green) shows an increase in VGlut1 intensity
in CaMKIINampt /mice. Scale bars, 20m. Data are presented as mean SEM. *p	 0.05; **p	 0.01; ***p	 0.001.
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puts reliably evoked fEPSPs and population spikes in control and
CaMKIINampt / mice. Consistent with the changes we ob-
served in dendritic morphology, however, we found that fEPSPs
and population spikes in slices from CaMKIINampt / mice
consistently required a large presynaptic fiber volley compared
with controls (Fig. 5A,B). We quantified this effect by analyzing
the ratio of presynaptic fiber volley amplitude required to evoke a
maximal population spike. Although the difference did not reach
statistical significance, the ratio of presynaptic volley to maximal
population spike was only 4.7 2.5% in control mice (Fig. 5A),
consistent with prior work (Bukalo and Dityatev, 2006), whereas
the ratiowas 110.9 85.1% inCaMKIINampt /mice (Fig. 5B).
Furthermore, even with maximal stimuli, we consistently ob-
served larger fiber volleys and smallermaximal population spikes
in CaMKIINampt /mice compared with controls (maximal
fiber volleys: controlmice: 0.12 0.05mV;CaMKIINampt /
mice: 0.78 0.27mV; Student’s t test, p
0.046, n 5; maximal population spikes:
control mice: 3.67  0.70 mV;
CaMKIINampt / mice: 1.90  0.44
mV; Student’s t test, p  0.07, n  5).
These findings indicate that, despite hav-
ing intact synaptic responses,
CaMKIINampt / mice have altered
inputs into CA1 and diminished so-
matic excitability in response to synap-
tic activation.
Presynaptic alterations in the Schaffer
collateral pathway can affect paired-pulse
plasticity (Capogna, 1998; Nicoll and
Malenka, 1999). Therefore, we assessed
fEPSPs and population spikes (PSs) of
control and CaMKIINampt / mice
upon paired-pulse stimulation deliv-
ered at an interval of 21 ms. To quantify
changes in paired-pulse plasticity, we
first determined the amplitude of a
fEPSP that generated a 50% maximal PS
evoked by the initial stimulation (Fig.
5C, top) and then found the size of the
second PS generated by the equivalent
fEPSP evoked by the second (paired)
stimulation (Fig. 5C, bottom). As is typ-
ically seen (Capogna, 1998), we ob-
served paired-pulse depression of PSs in
control slices after adjusting for the size
of dendritic fEPSPs (second PS 
40.3  18.7% of initial PS amplitude,
n  6). In contrast, slices from
CaMKIINampt / mice did not ex-
hibit similar paired-pulse depression (sec-
ond PS  116.6  11.5% of initial PS
amplitude; Student’s t test, p 0.004, n
7). A typical pattern of paired-pulse PS de-
pression in a slice from a control mouse
highlights differences between control (Fig.
5C, bottom left) and CaMKIINampt /
mice (Fig. 5C, bottom right). These results
again support the conclusion that
CaMKIINampt / mice have altered so-
matic excitability in response to synaptic in-
puts.
CaMKIINampt /mice exhibit hyperactivity andmild
sensorimotor deficits
Considering the histological abnormalities observed in 2- to
3-month-old CaMKIINampt / mice, we conducted several
behavioral analyses to evaluate the possibility that disturbances in
hippocampal function could lead to impaired performance on
certain behavioral tests. We first conducted a 1 h locomotor
activity test and a battery of sensorimotor measures as general
assessments of health and to determine whether certain non-
associative behavioral disturbances were likely to affect learn-
ing and memory performance. In the 1 h locomotor activity
test, CaMKIINampt / mice exhibited a 2.8- to 3.8-fold in-
crease in ambulations (whole-body movements) over control
mice throughout the entire test session (Fig. 6A,B; rmANOVA,
genotype effect: F(1,27) 33.99, p	 0.00005). Significant differ-
Figure 5. CaMKIINampt / mice show altered Schaffer-collateral pathway physiology at 2–3 months of age. A,
Representative fEPSPs obtained from control mice show a small presynaptic volley (arrow) relative to the population spike
(n 5). Calibration: 1 mV, 5 ms. B, Representative fEPSPs obtained from CaMKIINampt /mice show a large presyn-
aptic volley (arrow) relative to the population spike (n 5). C, Assessment of PS amplitude (height) upon paired-pulse
stimulation. Because both dendritic fEPSPs and PS height are altered by paired-pulse stimulation, we used an analysis of IO
curves to calculate the size of fEPSP required to generate a half-maximal PS after the first (top) and second (bottom) paired
stimuli. The IO curves of the first stimuli in the top are repeated in the bottom for clarity. The left graphs show typical IO
curves for dendritic fEPSPs (circles) and PSs (triangles) in a slice from a control mouse. The stimulus intensity needed to
evoke a half-maximal PS by the first stimulation (top) was determined by the intersection of the horizontal 50% maximal
line with a line connecting the two points straddling the half maximal value (shown by the green solid line between two PS
points in black triangles in bottom). We then used this value to calculate the size of dendritic fEPSP required to generate a
PS of this magnitude, shown as the intersection of the upward red arrow and the solid blue line connecting two points
(black circles), on the initial fEPSP IO curve. We next calculated the stimulus intensity required for the second (paired)
stimulus to induce an equivalent fEPS, shown as a horizontal red arrow intersecting the dotted blue line, from the second
pulse fEPSP curve (white circles). At this stimulus intensity, we could then determine the PS amplitude generated by the
second stimulation, shown as a downward red arrow intersecting the dotted green line on the second PS curve (white
triangle). This analysis shows that the PS generated by a second stimulation at an equivalent fEPSP size is much smaller
than the PS produced by the initial stimulus, indicating the presence of significant paired-pulse depression. The right
graphs show a similar analysis of IO curves in a slice from a CaMKIINampt / mouse. The marked paired-pulse
depression of PS amplitude observed in the control slice is not seen in the CaMKIINampt / mouse, despite clear
paired-pulse potentiation of dendritic fEPSPs, manifest as a leftward shift in the fEPSP IO curves (black vs white circles). The
dashed arrow in the lower left graph depicts the 50%maximal fEPSP; this stimulus intensitywas used tomonitor fEPSPs in LTP studies.
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ences were also observed for each time
block during the test session (pairwise
comparisons, p 	 0.0003), but not for
main or interaction effects involving sex.
Control mice showed habituation over
the test period, exhibited by a significant
57% decrease (p  0.014) in ambulations
between blocks 1 and 6. In contrast,
CaMKIINampt / mice showed only a
22% decrease in ambulations (p  0.054).
In addition, CaMKIINampt / mice
exhibited a 1.4- to 2.8-fold increase in
exploratory behavior (instances of vertical
rearing) relative to control mice
(rmANOVA, genotype effect: F(1,27) 
21.70, p 0.0001), in both a sex- and time-
dependent manner (genotype  time:
F(5,135)  2.40, p  0.05, genotype  sex:
F(1,27)  5.99, p  0.021, and genotype 
sex time: F(5,135) 3.07, p 0.017). Spe-
cifically, male CaMKIINampt / mice
reared significantly more often than male
control mice (F(1,27)  23.06, p 0.0001),
whereas no differences were observed be-
tween the groups of female mice (Fig. 6C).
As with their ambulations, control mice
showed significant habituation of instances
of vertical rearing from block 1 to block 6
(53% decrease; F(1,27)  25.90, p 	
0.00005).Conversely,CaMKIINampt /
mice only showed a nonsignificant 9%
decrease in rearing, suggesting that habitu-
ation did not occur. The lack of habitua-
tion during activity testing also suggests
possible deficits in novelty acquisition
or other basic learning and memory
capabilities.
To assess possible alterations in emo-
tionality, we compared the activity and
exploration levels in the center versus the
periphery of the 1 h locomotor activity test
arena. Interestingly, CaMKIINampt /
mice made significantly more entries into
the center of the test arena (1.8-fold;
F(1,27)  7.08, p  0.013) and traveled a
significantly greater distance in the center
(1.9-fold; F(1,27)  6.00, p  0.021) than
control mice, suggesting a possible de-
crease in anxiety-like behaviors (Fig. 6D,E).
However, because CaMKIINampt /
and control mice did not differ in
terms of the percentage of time spent in
the center (Fig. 6F ) and because
CaMKIINampt / mice traveled a
significantly greater distance (Figure
6G; F(1,27) 29.31, p	 0.00005) and percentage of distance (Fig.
6H) in the peripheral zone of the arena, we cannot exclude the
possibility that differences observed in the “center” variables are pri-
marily due to the hyperactivity of the CaMKIINampt / mice
rather than an alteration in emotionality. In these “emotionality”
variables, we did not find any significant effects involving sex.
In the sensorimotor battery, CaMKIINampt / mice ex-
hibited performance deficits on three of seven of the tests com-
pared with control mice. Specifically, CaMKIINampt /mice
were not impaired on the platform, the 90° inclined screen, or the
inverted screen tests (data not shown). However, they took sig-
nificantly longer to move out of a small circumscribed area
(square) during the walking initiation test (2.3-fold; F(1,27) 
4.68, p  0.040), remained on an elevated ledge for a signifi-
cantly less time (40%; F(1,27)  30.14, p 	 0.00005), and took
significantly longer to climb down a pole (2.4-fold; F(1,27) 
Figure 6. CaMKIINampt /mice exhibit hyperactivity in the absence ofmajor sensorimotor deficits at 2–3months of age.
A–E, Evaluationof CaMKIINampt /mice (n15) and controlmice (n16) on the1h locomotor test. CaMKIINampt /
mice showedamuchhigher averagenumber of ambulations (A) and instances of vertical rearing (B) in eachof the six 10minblocks
of the testing period than did control mice. C, Differences between genotypes in levels of vertical rearing are more pronounced in
male CaMKIINampt / mice than female CaMKIINampt / mice. D–H, CaMKIINampt / mice showed a higher
number of entries into the center of the test arena (D) and average distance traveled in both the center (E) and the periphery of the
test arena (G) than control mice. The percentage of time spent in the center was similar between genotypes (F ), whereas the
percentage of distance spent in the periphery was higher in CaMKIINampt / mice (H ). I–K, Evaluation of
CaMKIINampt / mice (n 15) and control mice (n 16) on a battery of sensorimotor tests. CaMKIINampt / mice
showed increased time to initiatewalking (movement) out of a square (I ), decreased time to balance on a ledge (J ), and increased
time to climb down a pole (K ). Asterisks represent significance generated from unpaired Student’s t tests. ^ and ^^ represent
significance generated from rmANOVAs. Data are presented as mean SEM. *p	 0.05; **p	 0.01; ***p	 0.001.
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19.82, p  0.0001) than controls (Fig. 6I–K ). These results
suggest that CaMKIINampt / mice have mild sensorimotor
impairments in terms of speed to movement, coordination be-
tween the forelimbs and hindlimbs, and balance compared with
control mice.
CaMKIINampt /mice show impaired spatial cognition in
theMWM
To assess spatial learning and memory, we next evaluated
CaMKIINampt / and controlmice on theMWM. In the cued
trials of the MWM, CaMKIINampt / and control mice ini-
tially showed equivalent performance lev-
els with regard to escape path length (Fig.
7A). However, control mice rapidly im-
proved their performance in the subse-
quent three blocks of trials such that their
performance became far superior to that
of CaMKIINampt / mice during the
rest of training (rmANOVA, genotype ef-
fect: F(1,27)  17.18, p  0.0003; geno-
type  blocks of trials interaction: F(3,81)
 5.71, p  0.001). Indeed,
CaMKIINampt /mice exhibited signif-
icantly greaterpath lengths relative to the con-
trol group during blocks 2–4 (pairwise
comparisons, p 	 0.003). However, both
CaMKIINampt / and control mice
showed a significant decrease in path length,
or improved performance, from block 1 to
block 4 (F(1,27) 11.93, p 0.002; and F(1,27)
 72.11, p	 0.00005, respectively), suggest-
ing that some cued learning occurred
even in CaMKIINampt / mice.
CaMKIINampt /mice also exhibited sig-
nificantly slower swimmingspeedsonaverage
across blocks of trials relative to control mice
(Figure 7B; 22%decrease; rmANOVA, geno-
type effect: F(1,27) 46.21, p	 0.00005) and
for eachblockof trials (pairwise comparisons,
p	 0.0002). Because escape latency is directly
affected and confounded by differences in
swimming speeds, the significantly slower
swimming speeds in CaMKIINampt /
mice make escape latency an inappropriate
variable to assess performance. Therefore, the
latencydata arenot presentedhere.No signif-
icant effects involving sex were found during
the cued trials.
During acquisition training in the
place (spatial learning) condition of the
MWM, performance differences between
the groups became even greater. Across all
trial blocks, CaMKIINampt / mice
showed much longer path lengths than
control mice (Figure 7C; rmANOVAs, ge-
notype F(1,27) 72.16, p	 0.00005; geno-
type  blocks of trials interaction F(4,108)
 3.11, p  0.034). The performance of
CaMKIINampt / mice was signifi-
cantly impaired for blocks 2–4 (pairwise
comparisons, beyond Bonferroni correc-
tion, p 	 0.00005), whereas large differ-
ences were also observed for block 1
(F(1,27)  6.71, p  0.015). Specifically, CaMKIINampt
 /
mice initially showed a 1.5-fold longer path length in block 1 that
increased to 4.2-fold in block 5 (F(1,27)  9.58, p  0.005, and
F(1,27) 19.18, p 0.0002, respectively). However, as in the cued
trials, both groups showed some evidence of spatial learning,
although the performance of control mice was far superior.
Again, as in the cued trials, the CaMKIINampt / mice also
exhibited significantly decreased swimming speeds (Figure 7D;
18% decrease, genotype effect: F(1,27)  14.93, p  0.0006), al-
though this was dependent on the blocks of trials (genotype 
blocks of trials interaction: F(4,108)  2.79, p  0.030).
Figure7. CaMKIINampt /mice show impairments in hippocampal-dependent learning andmemory, but not LTP, at 2–3
months of age. A–F, Evaluation of CaMKIINampt /mice (n 15) and control mice (n 16) on the MWM. During both the
cued (A) and place (C) conditions of the MWM, CaMKIINampt /mice exhibited significantly longer path lengths to find the
platform relative to control mice. The swimming speed of CaMKIINampt /mice was significantly lower than control mice in
during acquisition of the cued (B) and the place (D) conditions of the MWM. During the probe condition of the MWM,
CaMKIINampt /mice exhibited significantly fewer platform crossings (E) and less time (F ) in the target quadrant relative to
control mice. G, CaMKIINampt /mice (n 7) and control mice (n 6) exhibit similar LTP at P60. H, Representative fEPSP
traces for CaMKIINampt /mice (top) and controlmice (bottom). Calibration: 1mV, 5ms.Data arepresentedasmean SEM.
*p	 0.05; **p	 0.01; ***p	 0.001.
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CaMKIINampt / mice swam signifi-
cantly slower than control mice for
blocks 1–3 (pairwise comparisons, p 	
0.008), although differences were also ob-
served during block 4 (pairwise compari-
son, p  0.015). Consistent with the poor
acquisition performance during the place tri-
als,CaMKIINampt /mice also exhib-
ited retention deficits during the probe
trial in terms of platform crossings (Fig-
ure 7E; genotype effect: F(1,27)  20.89,
p  0.0001) and time spent in the target
quadrant (Figure 7F; genotype effect:
F(1,27) 19.04. p 0.0002). Importantly,
control mice showed a spatial bias for the
target quadrant by spending significantly
more in that quadrant versus the times
spent in each of the other quadrants (p	
0.00005), whereas CaMKIINampt /
mice showed no such bias. Similar to the
results from the cued condition of the
MWM, no effects involving sex were
found for any of the variables from the
place or probe trials.
Based on the performance deficits exhib-
ited by CaMKIINampt / mice during
the cued trials, we investigated the possi-
bility that CaMKIINampt /mice may
have had visual impairments that com-
promised their ability to see proximal and
distal cues during MWM testing. How-
ever, imaging their retinas revealed no
gross defects relative to controls (data not
shown). In addition, assessment of visual
acuity (grating) thresholds by quantify-
ing optokinetic tracking behavior and evaluation of the pho-
topic and scotopic waves by electroretinography did not reveal
any differences between CaMKIINampt / and control mice
(data not shown).
Given the major impairments in spatial learning andmemory
that CaMKIINampt /mice displayed in all conditions of the
MWM, we suspected that there would be accompanying impair-
ments in hippocampal synaptic plasticity. Using a half maximal
fEPSP stimulus, we assessed LTP in P60 mice. To our surprise,
LTP in response to a single 100Hz 1 sHFSwas not significantly
different between groups (Fig. 7G). In controlmice, HFS resulted
in an increase in fEPSP slopes that was 189.5 23.1% of baseline
measured 60 min after HFS. In CaMKIINampt / mice, the
fEPSP slopes were 165.0 18.5% of baseline (Fig. 7H; Student’s
t test, p 0.43, n 5).
CaMKIINampt /mice perform abnormally on the
conditioned fear test
With these major spatial learning and memory deficits, we next
addressed the possibility thatCaMKIINampt /mice also had
cognitive deficits in nonspatial forms of learning andmemory by
evaluating the mice on the conditioned fear test. Analysis of the
baseline freezing data collected during the first 2 min of day 1 of
conditioned fear testing did not reveal any significant effects in-
volving genotype or sex (Fig. 8A). In contrast, the freezing data
during the training trials when a tone (CS) was paired with a foot
shock (US) on day 1 revealed significantly higher levels of
freezing in control mice, although this was somewhat depen-
dent on the minutes of the test and sex (rmANOVAs, genotype
effect: F(1,27)  41.02, p 	 0.00005; genotype  sex: F(1,27) 
4.27, p  0.048; genotype by minutes: F(2,54)  11.22, p 
0.0001). Control mice also froze significantly more often than
CaMKIINampt / mice during each minute of the tone/
shock (T/S) training (pairwise comparisons, p 	 0.003). On
average, across minutes during the T/S training, the freezing
levels of male and female CaMKIINampt / mice were sig-
nificantly lower than their respective controls (genotype 
sex: F(1,27) 10.90, p 0.003; genotype sex: F(1,27) 32.77,
p 	 0.00005, respectively).
During the first 2 min of the contextual fear test conducted
on day 2, CaMKIINampt / and control mice exhibited
similar levels of freezing. However, the freezing levels in
CaMKIINampt / mice subsequently dropped precipitously,
whereas the levels of control mice remained the same or slightly
increased across the test session, resulting in large differences
between the groups for minutes 5–8 (Figure 8B; rmANOVAs,
genotype effect: F(1,27)  5.91, p  0.022; genotype  minutes
interaction: F(7,189)  3.68, p  0.014). Specifically, the freezing
levels of the control mice were significantly greater than those of
CaMKIINampt / mice for minutes 5–8 (pairwise compari-
sons, p 	 0.0005). To assess levels of conditioning produced by
the training on day 1, we also conducted an additional analysis
comparing the average freezing levels during the 2 min baseline
on day 1 with the average freezing levels quantified during the
first 2min of contextual fear testing on day 2 (Fig. 8C). These first
2 min on day 1 and day 2 were significantly different from each
Figure 8. CaMKIINampt /mice show impairments in nonspatial hippocampal-dependent learning and memory at 2–3
months of age. A–D, Evaluation of fear conditioning in CaMKIINampt /mice (n 15) and control mice (n 16). A, On day
1, mice were subjected to T/S preconditioning. CaMKIINampt /mice froze significantly less than control mice both during
baseline measurements and in response to the T/S stimuli. B, On day 2, mice were placed in the same chamber used for the T/S
preconditioning to evaluate contextual fear. CaMKIINampt / mice froze significantly less than control mice. C, Both
CaMKIINampt / and control mice froze significantly more during the first 2min of the contextual fear conditioning test (day
2) than in the first 2 min of baseline measurements taken during preconditioning (day 1). D, On day 3, mice were placed in a new
chamber and the auditory tone stimuluswas presented again to evaluate cued fear. Relative to controlmice, CaMKIINampt /
mice froze significantly less both before and in response to the tone stimulus. Data are presented as mean SEM. *p	 0.05;
**p	 0.01; ***p	 0.001.
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other (averaged trials: F(1,27)  26.50, p 	 0.00005). However,
control andCaMKIINampt /mice each showed significantly
increased freezing levels across the two test days (F(1,27) 11.42,
p 0.002, andF(1,27) 15.28, p 0.006, respectively), suggesting
that equivalent levels of conditioning occurred in both groups.
This is an interesting finding considering the large differences
that were observed between the groups during the T/S training
on day 1. It may be that the two groups showed approximately
equivalent degrees of contextual fear conditioning, but the
precipitous drop in freezing of CaMKIINampt / mice re-
flected their difficulty inmaintaining high levels of freezing given
their proclivity toward hyperactivity.
Surprisingly, during the altered context baseline testing on day 3
(minutes 1–2), the freezing levels ofCaMKIINampt /micewere
significantly higher than those of controls (Figure 8D; genotype
effect: F(1,27) 5.03, p 0.033), although the magnitude of dif-
ferences were similar for minutes 1 (p  0.045) and 2 (p 
0.044). In contrast to the altered context baseline period, con-
trol mice exhibited greatly increased freezing levels relative to
the CaMKIINampt / mice during the auditory cue test. These
differencesbecame lessprominent as themicehabituated to the tone
over the test session (rmANOVAs, genotype effect: F(1,27)  9.47,
p  0.005; genotype by minutes interaction: F(7,189)  2.85, p 
0.012). Differences were significant beyond Bonferonni correc-
tion (p  0.05/8  0.0063) during minute 3 (p 	 0.00005),
although large differences were also observed during minutes 4
(p  0.009), 5 (p  0.017), 6 (p  0.026), and 7 (p  0.018).
There were no significant effects involving sex (rmANOVAs) for
any of the data from the contextual fear test (day 2) or the altered
context baseline or auditory cue test (day 3).
Given this impressive lack of freezing, we wondered whether
CaMKIINampt / mice were able to feel the shock and hear
the tone. Therefore, after completion of the conditioned fear test-
ing, we also evaluated the mice for their sensitivity to shock.
However, the shock sensitivity of control andCaMKIINampt /
mice did not reveal any significant differences between groups with
regard to the levels of shock that elicited flinching, vocalizing, or
running (data not shown). Thus, the differences in performance
levels between the two groups during the contextual fear and
auditory cue tests were not likely due to differences in shock
sensitivity. We also confirmed that none of the control or
CaMKIINampt /micewas deaf or severely hearing impaired,
nor did any of them have sensorimotor deficits that prevented
them from displaying normal startle magnitudes in response to
loud tones (data not shown).
In summary,CaMKIINampt /mice exhibited lower levels
of freezing compared with control mice during several phases of
the conditioned fear test, including T/S training, the middle and
later portions of the contextual fear test (day 2), and the early and
middle portions of the auditory cue test (day 3). Despite their
tendency to exhibit low levels of freezing, CaMKIINampt /
mice still showed some signs of contextual fear conditioning dur-
ing the early period of the test session on day 2, when their freez-
ing levels were equivalent to those of control mice.
CaMKIINampt /mice exhibit decreased levels of anxiety-
like behaviors
CaMKIINampt / mice showed some evidence of altered
emotionality, in terms of fear or anxiety-like behaviors, during
the 1 h locomotor activity test, as indexed by an increase in the
number of entries into, and the distance traveled in, the center of
the test arena compared with control mice (Fig. 6). However, this
interpretation was confounded by the hyperactivity of
CaMKIINampt / mice. Therefore, to determine whether
CaMKIINampt / mice exhibit abnormal levels of anxiety-
like behaviors, we evaluated an independent cohort of naive
CaMKIINampt / and control mice on the EPM. In the EPM,
CaMKIINampt /mice displayed decreased levels of anxiety-
like behaviors relative to the control mice in terms of the classic
variables of entries made, time spent, and distance traveled in the
open arms (Fig. 9A–C). Specifically, CaMKIINampt / mice
traveled significantly greater distances in the open arms com-
pared with controls (Figure 9A; rmANOVA, genotype effect:
F(1,23)  18.55, p  0.0003; genotype  test day interaction:
F(2,46) 6.78, p 0.006). Significant differences were found on
test days 1 (pairwise comparison, p  0.0001) and 3 (pairwise
comparison, p 0.008), with large differences also observed on
day 2 (p 0.034). Similar results were found with regard to time
spent in the open arms (Figure 9B; genotype effect: F(1,23) 
20.75, p 0.0001), inwhich significant differenceswere observed
on test day 1 (p 	 0.00005), although differences were also ob-
served on days 2 (p  0.033) and 3 (p  0.030). Last,
CaMKIINampt / mice also made significantly more entries
into the open arms compared with control mice, with the largest
differences observed on test day 3 (Figure 9C; genotype effect:
F(1,23) 9.84, p 0.005).
We also analyzed the three aforementioned open arm vari-
ables after normalizing values to reflect percentages that were
calculated with reference to the totals measured in both sets of
arms to counteract any differences in activity that might affect
the results. Analyzing these data produced very similar results
to those described in the previous paragraph, providing addi-
tional evidence that the CaMKIINampt / mice displayed
decreased levels of anxiety-like behaviors. Specifically,
CaMKIINampt /mice traveled a significantly greater per-
centage of distance the open arms out of the total distance
traveled compared with control mice on average across the 3
testdays(rmANOVA,genotypeeffect:F(1,23)16.15,p0.0005),with
significant differences on test day 1 (Fig. 9D; pairwise comparison, p
0.0002). Similarly, CaMKIINampt /mice spent a significantly
greater percentage of time in the open arms relative to the total time
spent in all of the arms compared with control mice (Figure 9E;
genotype effects: F(1,23) 18.07, p 0.0003), with significant group
differences being observed for test day 1 (p  0.0001) and large
differences found for days 2 (p  0.046) and 3 (p  0.027). Last,
CaMKIINampt /mice had a significantly higher percentage of
entries made into the open arms out of the total number of arm
entries on average across test days comparedwith controlmice (Fig-
ure 9F; genotype effect: F(1,23) 8.44, p 0.0008), with the largest
differences being observed on day 1 (p 0.024).
AlthoughCaMKIINampt /mice traveled longer distances
in the open arms of the EPM than control mice, the two groups
did not differ in the distance traveled in the relatively safe con-
fines of the closed arms (Fig. 9G). CaMKIINampt / mice
actually traveled a significantly shorter distance in the center area
compared with control mice (genotype effect: F(1,23) 8.04, p
0.009; genotype test day interaction: F(2,46) 8.78, p 0.001),
with significant differences being found for day 1 (p 0.002) and
large differences observed for day 2 (Fig. 9H; p  0.032). How-
ever, the two groups did not differ in the total distance traveled
throughout the EPM, thus providing additional evidence that
CaMKIINampt / mice exhibit abnormally low levels of
anxiety-like behaviors that are not dependent on differences in
general ambulatory activity (Fig. 9I ). No significant overall
effects involving sex were found from any of the rmANOVAs
conducted on the above-mentioned EPM variables. In conclu-
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sion, CaMKIINampt / mice exhib-
ited decreased anxiety-like behaviors in
the EPM. Although the most parsimoni-
ous interpretation of the data is that
CaMKIINampt / mice have lower
levels of an emotional state that may be
analogous to “anxiety,” their poor per-
formance on the MWM raises the possi-
bility that these mice may have a
diminished cognitive capacity to detect
threatening situations and thus do not
respond like control mice under such
circumstances.
Discussion
In this study, we tested the importance of
intracellular NAD biosynthesis from
nicotinamide by generatingmice lacking a
key NAD biosynthetic enzyme, Nampt,
in forebrain excitatory neurons. We show
that CaMKIINampt / mice develop
hippocampal and cortical atrophy, astro-
gliosis, microgliosis, and aberrant dendritic
morphology by 2–3 months of age. These
histological changeswere associatedwith al-
tered intrahippocampal connectivity and
abnormal behavior. Therefore, intracellular
Nampt-mediatedNADbiosynthesis is the
primary source of NAD for forebrain ex-
citatory neurons and is critical for neuronal
function and survival.
Consistent with the established fea-
tures of CaMKIICre driver mice (Tsien
et al., 1996; Luikart et al., 2005;Monteggia
et al., 2007; Wang et al., 2011a), we ob-
served a large reduction in Nampt cells,
particularly in the hippocampal CA1 sub-
region, and a significant reduction in total
hippocampal NAD levels. Nonetheless,
CaMKIINampt /mice also displayed remarkable hippocam-
pal changes without obvious apoptosis, necrosis, or autophagy.
An intriguing change in CaMKIINampt /mice is their atro-
phied and swollenMap2 dendrites, indicating altered neuronal
connectivity. Supporting this notion, electrophysiological assess-
ments revealed changes in the relationship between inputs and
outputs in CA1. Namely, CaMKIINampt / mice required
larger presynaptic volleys to evoke maximal population spike fir-
ing. Presynaptic volleys represent the summed discharge of ac-
tion potentials from afferent axons that arrive in CA1 after
Schaffer collateral pathway stimulation. Therefore, larger presyn-
aptic volleys suggest the need to recruit more presynaptic neu-
rons and perhaps altered action potential initiation, propagation,
and/or amplitude (Soleng et al., 2003; Meeks and Mennerick,
2004). In CaMKIINampt /mice, Schaffer collateral pathway
stimulation triggered synaptic responses (fEPSPs) that promoted
spike firing. Moreover, CA1 glutamatergic synapses, once acti-
vated, could generate and sustain LTP. The normal fEPSPs ob-
served in CaMKIINampt / mice indicate that basal synaptic
transmission, presynaptic neuron transmitter release, and post-
synaptic neuronal responses are intact and not a primary defect,
although more systematic evaluation could uncover changes in
these parameters as well. Such defects in hippocampal function
have not been observed in other models of disease (Schiff and
Somjen, 1985; Young and Somjen, 1992; Mitani et al., 1993),
neurotransmitter imbalances (Konnerth andHeinemann, 1983),
ionic imbalances (Balestrino et al., 1986), glycolytic blockade
(Tekko¨k and Krnjevic´, 1995), or neuronal loss (Patterson et al.,
1996). Importantly, excitotoxicity and glycolytic blockade in-
crease presynaptic volley amplitude by increasing sodium entry
and facilitating axonal excitability (Tekko¨k and Krnjevic´, 1996;
Sua´rez et al., 2005; Winegar and MacIver, 2006). Therefore, it is
possible thatCaMKIINampt /hippocampal neurons have an
altered firing threshold.
With such profound histological and electrophysiological ab-
normalities, we predicted that CaMKIINampt /mice would
show behavioral changes associated with altered CA1 function,
including hyperactivity, reduced anxiety-like behaviors, and im-
paired cognition (Fanselow, 2000; Kubik et al., 2007; Barkus et
al., 2010; Langston et al., 2010). Indeed, CaMKIINampt /
mice showed robust changes in all of the above. Most strikingly,
CaMKIINampt /mice required longer escape path lengths to
find the platform in both the cued and place (spatial learning)
conditions of the MWM. Although the performance of
CaMKIINampt / mice was substantially inferior to control
mice, they nevertheless showed improvement over time, suggest-
ing some spatial learning. However, the lack of retention dis-
played by CaMKIINampt / mice during the probe trial
implies that spatial learning and/or retention was minimal. This
Figure 9. CaMKIINampt / mice have impaired ability to exhibit anxiety. A–I, Evaluation of CaMKIINampt / mice
(n 12) and control mice (n 15) on the EPM. CaMKIINampt /mice exhibited increased open arm distance (A), open arm
time (B), and open arm entries (C) relative to control mice, which corresponded to increased percentage distance traveled in open
arms (D), time spent in open arms (E), and entries into open arms (F ) relative to control mice. CaMKIINampt / mice also
displayed similar closedarmdistance (G) as controlmice, but decreased center distance (H ), particularly on the first dayof training.
CaMKIINampt /mice showed similar total arm distance (I ) as control mice. Data are presented asmean SEM. *p	 0.05;
**p	 0.01; ***p	 0.001.
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impairment in the MWM performance of CaMKIINampt /
mice is particularly surprising in light of their intact LTP. Indeed,
previous work has strongly correlated MWM performance (Jef-
fery and Morris, 1993; Tombaugh et al., 2002) and expression of
immediate early genes including Egr1 (Davis et al., 2003) and Arc
(Kubik et al., 2007) with LTP. Therefore, CaMKIINampt /
mice present an interesting discrepancy in functional, electro-
physiological, and histopathological phenotypes.
Conditioned fear testing revealed that cognitive deficits in
CaMKIINampt /mice extend to Pavlovian conditioning in-
volving nonspatial learning and memory. During the T/S train-
ing, CaMKIINampt / mice showed much less freezing
behavior than control mice, suggesting that the foot shocks pro-
duced less fear in these mice or that their hyperactivity made it
difficult for them to remain motionless. CaMKIINampt /
mice displayed similar levels of freezing as control mice during
the first 2 min of the contextual fear testing, but after these first 2
min, and during the auditory cue testing, CaMKIINampt /
mice showed little freezing behavior. Therefore, the T/S training
may have produced some conditioned or generalized fear in
CaMKIINampt / mice, the behavioral expression of which
was compromised by hyperactivity. It will be interesting to eval-
uate aversive conditioning in CaMKIINampt /mice by pro-
cedures that do not use freezing as a primary outcome.
Our results suggest that CaMKIINampt / mice have
cognitive deficits that are coupled with hyperactivity and ab-
normally low levels of anxiety-like behavior. Importantly, our
findings that CaMKIINampt /mice were more active than
control mice in the threatening open arms of the EPM suggest
that they may exhibit abnormal hyperactivity in environments
that contain aversive stimuli. Additional studies are needed to
determine whether the reduced anxiety-like behaviors in
CaMKIINampt / mice represent altered emotionality or an
inability to perceive danger. It is also interesting that
CaMKIINampt / male mice showed more extensive body
weight and activity phenotypes thanCaMKIINampt / female
mice, considering that reducing Nampt activity in peripheral tis-
sues generates stronger phenotypes in female mice than male
mice (Revollo et al., 2007; Ramsey et al., 2008).
Although the hyperactivity, impaired learning and memory,
and reduced levels of anxiety-like behaviors observed in
CaMKIINampt / mice correspond nicely with a loss of CA1
functionality, their impaired performance on the auditory cue
testing does not (Fanselow, 2000; Kubik et al., 2007; Barkus et al.,
2010; Langston et al., 2010). One explanation for this discrepancy
is that the CA1 atrophy in CaMKIINampt / mice disrupted
anatomical connections between CA1 and other brain areas, in-
cluding the entorhinal cortex, DG, CA3, and subiculum areas,
and thereby impaired their functions (Canto´ et al., 2008; Langs-
ton et al., 2010; Piskorowski and Chevaleyre, 2012). Indeed, mul-
tiple regions of the cortex have been implicated in fear responses
(Casey et al., 2013). It is also possible that the poor performance
of CaMKIINampt / mice on the auditory cue testing is the
result of their hyperactivity. However, additional control groups
(e.g., shock alone or “unpairing” of the tone and shock) are
needed to determine whether auditory cue performance impair-
ments result from “true conditioning” or other processes such as
sensitization. Given the CA1 pathology in CaMKIINampt /
mice, we included the auditory cue testing as a control for the
specificity of the contextual fear performance deficit.
Importantly, the collective cellular, physiological, and be-
havioral phenotypes displayed by CaMKIINampt / mice
are specific to loss of Nampt-mediated NAD biosynthesis.
CaMKIICre-driven deletion of multiple other factors produces
forebrain degeneration, but with profoundly different chronolo-
gies, pathways of cell death, and behavioral effects from those we
observed (So¨rensen et al., 2001; Tabuchi et al., 2009; He´bert et al.,
2010). Therefore, the phenotypes of CaMKIINampt / mice
cannot be equated with simple regional death and dysfunction.
Instead, the complex array of phenotypes in CaMKIINampt /
mice, in the absence ofmajor health or sensory impairments, poten-
tially place CaMKIINampt / mice as a novel model of CA1
dysfunction. Such amodel has considerable value because CA1 sus-
tains more damage than other hippocampal subregions in many
prevalent diseases and conditions, including ischemia (Calabresi et
al., 2003; Crepel et al., 2003; Nikonenko et al., 2009), excitotoxicity
(Stanika et al., 2010), status epilepticus (doNascimento et al., 2012),
and Alzheimer’s disease (Apostolova et al., 2010; Costafreda et al.,
2011; Padurariu et al., 2012).
Currently, the mechanism(s) downstream of Nampt is un-
known. Although NAD is best known for redox recycling, it
also functions as a substrate for several families of enzymes, in-
cluding sirtuins (e.g., Sirt1), PARPs (e.g., Parp1), and CD38/157
cADP-ribose synthases (Houtkooper et al., 2010; Stein and Imai,
2012).However, theCaMKIINampt / phenotypes do not ap-
pear to result from loss of Sirt1 or Parp1 function. CaMKII-
driven loss of Sirt1 does not generate overt CA1 and cortical
atrophy (data not shown). Moreover, both deletion of Sirt1 (Gao
et al., 2010;Micha´n et al., 2010) and inhibition of Parp1 (Fonta´n-
Lozano et al., 2010) impair LTP. Furthermore, neither Sirt1 (Gao
et al., 2010;Micha´n et al., 2010;Wu et al., 2011; Gra¨ff et al., 2013)
nor Parp1 (Fonta´n-Lozano et al., 2010) conclusively affect activ-
ity. Conversely, it is plausible that loss of CD38/157 activity con-
tributes to CaMKIINampt / phenotypes because CD38/157
generates the second messenger cADP-ribose, which contributes
to calcium mobilization via ryanodine receptors (Sauve, 2008;
Young and Kirkland, 2008; Houtkooper et al., 2010).
There is clearly an impetus to investigate novel molecules in-
volved in CA1 function. Cerebral ischemia, childhood-onset psy-
chiatric disorders, and dementia are major causes of death and
disability (Nikonenko et al., 2009; Frisardi et al., 2010; Robertson
and Feng, 2011; Sartori et al., 2011; Kvajo et al., 2012). Establish-
ing animalmodels is essential for understanding the pathology of
these diseases, yet this is difficult because of their multifaceted
environmental and genetic causes (Kvajo et al., 2012). To our
knowledge, this is the first study to show that forebrain excitatory
neuron ablation ofNampt has serious repercussions for neuronal
function and survival, which affects associated cognitive capabilities
and behaviors. Further investigation of CaMKIINampt / mice
should provide valuable information regarding CA1 and cortical
neuron vulnerability, function, and properties.
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